Salt Substitution Cuts Risk for Recurrent Stroke
By Lori Solomon HealthDay Reporter
MONDAY, Feb. 10, 2025 -- Salt substitution is safe and reduces the risk for stroke recurrence and death among patients with stroke, according to a study published online Feb. 5 in JAMA Cardiology.
Xiong Ding, M.P.H., from Wuhan University in China, and colleagues evaluated the effects of salt substitutes versus regular salt on the incidence of recurrent stroke and mortality among patients with stroke. The analysis included 15,249 patients with stroke assigned to a salt substitute (75 percent sodium chloride and 25 percent potassium chloride by mass) or regular salt.
During a median 61.2 months of follow-up, the researchers found that recurrent stroke was significantly lower in the salt substitute group versus regular salt group (rate ratio, 0.86). Even larger effects were seen for hemorrhagic stroke (relative reduction, 30 percent). Additionally, death rates were also significantly lower in the salt substitute group (rate ratio, 0.88), with larger effects on stroke-related deaths (relative reduction, 21 percent). There was no significant difference observed between the groups for hyperkalemia.
"Results of this cluster trial demonstrate that salt substitution was safe, along with reduced risks of stroke recurrence and death, which underscores large health gains from scaling up this low-cost intervention among patients with stroke," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.